2022
Two Bonebridge bone conduction hearing implant generations: audiological benefit and quality of hearing in children
ŠIKOLOVÁ, Soňa, Milan URÍK, Dagmar HOŠNOVÁ, Vít KRUNTORÁD, Michal BARTOŠ et. al.Základní údaje
Originální název
Two Bonebridge bone conduction hearing implant generations: audiological benefit and quality of hearing in children
Autoři
ŠIKOLOVÁ, Soňa (203 Česká republika, domácí), Milan URÍK (703 Slovensko, garant, domácí), Dagmar HOŠNOVÁ (203 Česká republika, domácí), Vít KRUNTORÁD (203 Česká republika, domácí), Michal BARTOŠ (203 Česká republika, domácí), Oldřich MOTYKA (203 Česká republika) a Petr JABANDŽIEV (203 Česká republika, domácí)
Vydání
European Archives of Oto-Rhino-Laryngology, New York, Springer, 2022, 0937-4477
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30206 Otorhinolaryngology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.600
Kód RIV
RIV/00216224:14110/22:00124985
Organizační jednotka
Lékařská fakulta
UT WoS
000695739900001
Klíčová slova anglicky
Active transcutaneous bone conduction implant; Children; Quality of lif; Atresia; Localisation; Hearing outcomes
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 14. 2. 2024 14:15, Mgr. Tereza Miškechová
Anotace
V originále
Purpose The study aimed to evaluate audiological benefits, quality of hearing and safety of two Bonebridge generation: BCI601 and BCI602 (MED-EL, Innsbruck, Austria) in children. Methods Twelve children were implanted: five BCI601 and seven BCI602 comprising of ten conductive hearing loss, and two single sided deaf SSD subjects. Audiological outcomes tested were sound field audiometry, functional gain, speech recognition threshold (SRT50), speech recognition in noise (SPRINT) and localisation abilities. Subjective measures were Speech, Spatial and Qualities of Hearing Scale (SSQ12). Results The mean FG with the BCI601 was 25.0 dB and with the BCI602 28.0 dB. The benefit in SRT50 was 23.2 dB and 33.8 dB, respectively. The mean benefit in SPRINT was 15% and 6.7% and the localisation ability improved from 33.3° to 16° and from 26.2° to 17.6°, respectively. The two SSD subjects reported a FG of 17 dB, a benefit in SRT50 of 22.5 and a benefit in SPRINT of 20%. Subjective outcomes improved significantly and even exceeded the values of their age-and sex matched normal hearing peers. One revision was reported: a retroauricular emphysema above the implant occurred 12 months post-OP, it was resolved operatively with the implant still being functional. Conclusion The pediatric cohort reports significant audiological benefit, even exceeding that of the age- and sex matched control. The combination of the high safety and audiological benefit makes the Bonebridge a comfortable and effective option in hearing rehabilitation in children.
Návaznosti
MUNI/A/1118/2020, interní kód MU |
| ||
MUNI/A/1132/2021, interní kód MU |
| ||
MUNI/A/1365/2022, interní kód MU |
|